Jan Van Ruymbeke Euro CEO of Daiichi Sankyo
This article was originally published in Scrip
Jan Van Ruymbeke has been appointed CEO of Daiichi Sankyo Europe, replacing Reinhard Bauer who is retiring after serving 10 years in this position. Mr Van Ruymbeke will take over in October. Until the end of June he was executive vice-president of Grünenthal, leading the company's business in Latin America.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.